Page last updated: 2024-10-31

mianserin and Akinetic-Rigid Variant of Huntington Disease

mianserin has been researched along with Akinetic-Rigid Variant of Huntington Disease in 3 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonelli, RM2
Költringer, P1
Kenner, L1
Reisecker, F1
Bonelli, R1
Sturdy, JL1
Mahapatra, SB1

Other Studies

3 other studies available for mianserin and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Mirtazapine in suicidal Huntington's disease.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:3

    Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Huntington Disease; Mianserin;

2003
Reversible Huntington's disease?
    Lancet (London, England), 1998, Nov-07, Volume: 352, Issue:9139

    Topics: Antipsychotic Agents; Caudate Nucleus; Disease Progression; Haloperidol; Humans; Huntington Disease;

1998
Mianserin and mania.
    The British journal of psychiatry : the journal of mental science, 1988, Volume: 153

    Topics: Bipolar Disorder; Female; Humans; Huntington Disease; Mianserin; Middle Aged

1988